Spots Global Cancer Trial Database for liver metastases
Every month we try and update this database with for liver metastases cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Treatment of Liver Metastases With Electrochemotherapy (ECTJ) Phase II | NCT02352259 | Liver Metastase... | Electrochemothe... Cliniporator Vi... Bleomycin PHC 1... | 18 Years - | Institute of Oncology Ljubljana | |
| Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver | NCT00492999 | Colorectal Canc... Metastatic Canc... | dexamethasone floxuridine fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer | NCT00003941 | Mediastinal Can... Metastatic Canc... Testicular Germ... | bleomycin sulfa... filgrastim cisplatin etoposide ifosfamide bone marrow abl... peripheral bloo... | 16 Years - 50 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| COLLISION Trial - Colorectal Liver Metastases: Surgery vs Thermal Ablation | NCT03088150 | ColoRectal Canc... Liver Metastasi... Liver Metastase... Surgery | Thermal ablatio... Surgical resect... | 18 Years - | Amsterdam UMC, location VUmc | |
| FOLFOXIRI With or Without Cetuximab as First-line Treatment of Patients With Non-resectable Liver - Only Metastatic Colorectal Cancer | NCT02063529 | Metastatic Colo... | FOLFOXIRI + Cet... FOLFOXIRI | 18 Years - 65 Years | Sun Yat-sen University | |
| Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer | NCT00005842 | Cancer | trastuzumab tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
| Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms | NCT01640522 | Hepatocellular ... Primary Liver C... Bile Duct Cance... Pancreatic Canc... Gallbladder Can... Colorectal Carc... Liver Metastase... | Collaborative C... Enhanced usual ... | 18 Years - | University of Pittsburgh | |
| Metabolic Radiotherapy After Complete Resection of Liver Metastases in Patient With Digestive Neuroendocrine Tumor | NCT02465112 | Digestive Neuro... Metabolic Radio... Resection Liver Metastase... | In111-Pentetréo... simple monitori... | 18 Years - | GERCOR - Multidisciplinary Oncology Cooperative Group | |
| Irinotecan Drug-eluting Bead Liver Embolisation Registry | NCT03697044 | Colorectal Canc... Liver Metastase... | Irinotecan Drug... | 18 Years - 80 Years | The Christie NHS Foundation Trust | |
| Effect of Hepatectomy on the Prognosis of Patients With Nasopharyngeal Carcinoma Liver Metastases | NCT05771025 | Nasopharyngeal ... Liver Metastase... | Hepatectomy | 18 Years - 70 Years | Fudan University | |
| Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer | NCT01706432 | Central Nervous... Invasive Ductal... Invasive Ductal... Invasive Lobula... Invasive Lobula... Liver Metastase... Lobular Breast ... Lung Metastases Male Breast Can... Medullary Ducta... Mucinous Ductal... Papillary Ducta... Recurrent Breas... Stage IV Breast... Tubular Ductal ... Tumors Metastat... | hyperfractionat... laboratory biom... stereotactic ra... | 18 Years - | University of Chicago | |
| Partial Liver Segment 2/3 Transplantation Study | NCT02215889 | Colorectal Canc... | Liver transplan... | 18 Years - | Oslo University Hospital | |
| ctDNA-guided Adjuvant Chemotherapy in Liver Metastasis of Colorectal Cancer | NCT05815082 | Colorectal Canc... Liver Metastase... Circulating Tum... Chemotherapy Ef... | Colorectal canc... FOLFOX chemothe... | 18 Years - 75 Years | Sixth Affiliated Hospital, Sun Yat-sen University | |
| Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms | NCT01640522 | Hepatocellular ... Primary Liver C... Bile Duct Cance... Pancreatic Canc... Gallbladder Can... Colorectal Carc... Liver Metastase... | Collaborative C... Enhanced usual ... | 18 Years - | University of Pittsburgh | |
| Systemic Therapy With or Without Upfront Transarterial Embolization for Inoperable Liver Metastasis of Neuroendocrine Tumors | NCT01755182 | Neuroendocrine ... | approved pharma... TAE | 18 Years - 80 Years | National Cancer Institute, Naples | |
| Biological Effect of Nab-paclitaxel Combined to Gemcitabine in Metastatic Pancreatic Cancer | NCT02174887 | Pancreatic Aden... | Nab-paclitaxel ... | 18 Years - | Institut Paoli-Calmettes | |
| Liver Transplantation for Unresectable GIST Liver Metastases | NCT04825470 | Liver Diseases Liver Cancer Liver Metastase... Liver Neoplasms Liver Mass Liver Carcinoma Liver Transplan... Liver Transplan... GIST GIST, Malignant Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Metastases to L... Metastatic Live... Metastasis Metastases Liver Transplan... Transplant Onco... | Liver Transplan... | 18 Years - | Hospital Universitario Virgen de la Arrixaca | |
| FOLFIRI and Sunitinib in Metastatic Colorectal Cancer | NCT00806663 | Metastatic Colo... Liver Metastase... | sunitinib added... | 18 Years - 80 Years | Central European Society for Anticancer Drug Research | |
| A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer | NCT06130280 | Colorectal Canc... Liver Metastase... | MR Guided Singl... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases | NCT05588388 | Extensive-stage... Liver Metastase... | Bevacizumab | - | Cedars-Sinai Medical Center | |
| Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery | NCT00835679 | Liver Metastase... Mucinous Adenoc... Mucinous Adenoc... Recurrent Colon... Recurrent Recta... Signet Ring Ade... Signet Ring Ade... Stage IV Colon ... Stage IV Rectal... | cetuximab dasatinib therapeutic con... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer | NCT00482222 | Colorectal Canc... Metastatic Canc... | cetuximab capecitabine fluorouracil leucovorin calc... oxaliplatin study of socioe... adjuvant therap... neoadjuvant the... quality-of-life... | 18 Years - | University of Southampton | |
| TANGO-LIVER Three Arm Nuclear Growth Observation in Liver Surgery | NCT06050200 | Liver Metastase... Liver Cancer Liver Neoplasms Liver Metastasi... | PVE LVD ALPPS | 18 Years - 80 Years | Medical University of Warsaw | |
| DNX-2440 for Resectable Colorectal Liver Metastasis | NCT04714983 | Liver Metastase... Liver Metastasi... Colorectal Canc... Breast Cancer Gastric Cancer Periampullary C... Melanoma Renal Cell Canc... Sarcoma Squamous Cell C... Gastrointestina... | DNX-2440 | 18 Years - | DNAtrix, Inc. | |
| Prospective Cohort Study on Thermal Ablation of Malignant Liver Tumors | NCT06179602 | Liver Cancer Liver Metastase... Liver Metastasi... Hepatocellular ... | 18 Years - 110 Years | Leiden University Medical Center | ||
| Biological Therapy in Treating Women With Breast Cancer That Has Spread to the Liver | NCT00301106 | Breast Cancer Metastatic Canc... | adenovirus-medi... | 18 Years - 85 Years | Icahn School of Medicine at Mount Sinai | |
| Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies. | NCT06321640 | Breast Cancer Lung Cancer Melanoma Head and Neck C... Urothelial Carc... Colorectal Canc... Liver Metastase... Lung Metastases | Cohort A: prima... Cohort B: local... Cohort C: metas... Cohort D: Progr... Cohort E: Hemat... Cohort F: Toxic... | 18 Years - | European Institute of Oncology | |
| Comparison Between LDCT With DL Recontruction and Standard Dose CT | NCT05324046 | Liver Metastase... | contrast-enhanc... | 20 Years - 85 Years | Seoul National University Hospital | |
| Toripalimab,Celecoxib and Regorafenib in the Treatment of Refractory Advanced Colorectal Cancer | NCT05933980 | Colorectal Canc... Liver Metastase... MSS | Rego+Tori+Cele | 18 Years - 100 Years | Sun Yat-sen University | |
| Simultaneous vs. Staged Resection of Colorectal Cancer With Synchronous Liver Metastases | NCT06200831 | Colorectal Canc... Colorectal Neop... Liver Metastasi... Liver Metastase... | Staged resectio... Simultaneous re... | 18 Years - 80 Years | Oslo University Hospital | |
| Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer | NCT01320683 | Liver Metastase... Recurrent Colon... Recurrent Recta... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta... | oxaliplatin leucovorin calc... fluorouracil bevacizumab yttrium Y 90 DO... laboratory biom... pharmacological... irinotecan hydr... | 18 Years - | City of Hope Medical Center | |
| Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery | NCT01189227 | Colorectal Canc... Metastatic Canc... | Postoperative c... Perioperative c... | 18 Years - | NSABP Foundation Inc | |
| Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases | NCT00866944 | Liver Metastase... Colorectal Canc... | Adecatumumab Adecatumumab an... FOLFOX 4 | 18 Years - | Amgen Research (Munich) GmbH | |
| Matrix Metalloproteinases After Surgery and/or Radiofrequency Ablation in Patients With Liver Metastases From Colorectal Cancer | NCT00899210 | Colorectal Canc... Metastatic Canc... | laboratory biom... cryosurgery radiofrequency ... therapeutic con... | 18 Years - | National Cancer Institute (NCI) | |
| Preoperative CRT With or Without Induction Chemotherapy for Rectal Cancer With Liver Metastases | NCT01643070 | Rectal Cancer Liver Metastase... | Capecitabine, O... Radiotherapy | 20 Years - 75 Years | Asan Medical Center | |
| Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer | NCT00043004 | Colorectal Canc... Metastatic Canc... | bevacizumab FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin conventional su... radiofrequency ... | 18 Years - 80 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Proton Therapy in the Treatment of Liver Metastases | NCT01697371 | Liver Metastase... | Proton Proton Radiatio... | 18 Years - | Loma Linda University | |
| Liver Transplantation for Unresectable GIST Liver Metastases | NCT04825470 | Liver Diseases Liver Cancer Liver Metastase... Liver Neoplasms Liver Mass Liver Carcinoma Liver Transplan... Liver Transplan... GIST GIST, Malignant Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Metastases to L... Metastatic Live... Metastasis Metastases Liver Transplan... Transplant Onco... | Liver Transplan... | 18 Years - | Hospital Universitario Virgen de la Arrixaca | |
| Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery | NCT00513266 | Colorectal Canc... Metastatic Canc... | bevacizumab cetuximab fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin laboratory biom... adjuvant therap... biopsy conventional su... neoadjuvant the... | 18 Years - 70 Years | National Cancer Institute (NCI) | |
| Radiolabeled Glass Beads in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery | NCT00532740 | Liver Cancer Metastatic Canc... | Yttrium Y 90 gl... | 18 Years - | Northwestern University | |
| Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Breast Cancer | NCT01387373 | Metastatic Brea... Liver Metastase... | oxaliplatin, ca... | 18 Years - | Herlev Hospital | |
| Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer | NCT00438737 | Colorectal Canc... Metastatic Canc... | bevacizumab cetuximab fluorouracil leucovorin calc... oxaliplatin adjuvant therap... conventional su... neoadjuvant the... | 18 Years - 80 Years | National Cancer Institute (NCI) | |
| Study of NS-9 in Patients With Liver Metastases | NCT00094003 | Liver Neoplasms Neoplasm Metast... Local Neoplasm ... | NS-9 [Poly I: P... | 18 Years - | NS Pharma, Inc. | |
| FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer | NCT00724503 | Colorectal Canc... Colorectal Carc... Liver Metastase... | SIR-Spheres ytt... Systemic chemot... | 18 Years - | Sirtex Medical | |
| Minimally Invasive Liver Surgery for Metastases From Colorectal Cancer: Oncologic Outcome and Prognostic Factors | NCT01356706 | Long-term Oncol... | 18 Years - 90 Years | University Hospital, Gasthuisberg | ||
| EXtended CriteriA Treatment for LIver Metastases and Heavy Tumour BURden | NCT04840186 | Liver Metastase... Colorectal Canc... | Liver-resection... 2nd line chemot... | 18 Years - | Oslo University Hospital | |
| Intrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal Melanoma | NCT04935229 | Metastatic Uvea... | SD-101 Nivolumab Ipilimumab Nivolumab and R... | 18 Years - | TriSalus Life Sciences, Inc. | |
| Exploratory Study on Combined Conversion Immunotherapy for Liver Metastasis of MSS Type Initial Unresectable Colorectal Cancer Based on Gene Status | NCT05409417 | Colorectal Canc... Liver Metastase... | Experimental dr... | 18 Years - 75 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| TheraSphere Selective Internal Radiation Therapy (SIRT) as Treatment for Neuroendocrine Tumours With Liver Mets | NCT04362436 | Neuroendocrine ... Liver Metastase... | TheraSpheres Se... | 18 Years - | Imperial College London | |
| The Value of Laparoscopic Ultrasound in Patients Undergoing Laparoscopic Resection for Cancer of the Colon or Rectum | NCT02079389 | Colon Cancer Rectum Cancer Liver Metastase... | Lap+Lus | 18 Years - | Odense University Hospital | |
| Conversion Therapy of RAS/BRAF Wild-Type Colorectal Cancer Patients With Initially Unresectable Liver Metastases | NCT04687631 | Colorectal Canc... Liver Metastase... | mFOLFOXIRI plus... mFOLFOXIRI Plus... | 18 Years - 75 Years | Fudan University | |
| TACE Associated to Systemic Bevacizumab for the Treatment of Refractory Liver Metastases From Colorectal Cancer | NCT03732235 | Liver Metastasi... | TACE+ systemic ... FOLFIRI+Bevaciz... TACE | 18 Years - | International Group of Endovascular Oncology | |
| Prognosis of One-stage Hepatectomy for Bilobar Colorectal Metastases | NCT01683357 | Liver Metastase... | Hepatectomy | - | University of Milan | |
| Biological Effect of Nab-paclitaxel Combined to Gemcitabine in Metastatic Pancreatic Cancer | NCT02174887 | Pancreatic Aden... | Nab-paclitaxel ... | 18 Years - | Institut Paoli-Calmettes | |
| Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery | NCT01189227 | Colorectal Canc... Metastatic Canc... | Postoperative c... Perioperative c... | 18 Years - | NSABP Foundation Inc | |
| A Model for Predicting the Efficacy of Conversion Therapy for Patients With Colorectal Cancer Liver Metastases by the Detection of 5-hydroxymethylcytosine (5-hmC) in Plasma Cell-free DNA | NCT03679039 | Colorectal Canc... | 18 Years - | Fudan University | ||
| Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum | NCT00005860 | Cancer | floxuridine leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655) | NCT00023868 | Colorectal Canc... Metastatic Canc... | FOLFIRI regimen cisplatin doxorubicin hyd... fluorouracil irinotecan hydr... leucovorin calc... mitomycin C | 18 Years - 120 Years | American College of Radiology Imaging Network | |
| Stenting and Resection for Stage IV Colorectal Cancer Endoscopic Stenting and Colorectal Resection in Stage IV | NCT03451643 | Colorectal Neop... | ENDOSCOPIC PLAC... | 50 Years - 85 Years | University of Roma La Sapienza | |
| Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver Metastases | NCT01508000 | Colorectal Canc... Liver Metastase... KRAS Wild Type ... | FOLFOX6 Bevacizumab Panitumumab Surgery | 18 Years - 75 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to Liver | NCT01473004 | Stage IV Uveal ... | Sir-Spheres® | 18 Years - | Thomas Jefferson University | |
| CAR-T Hepatic Artery Infusions and Sir-Spheres for Liver Metastases | NCT02416466 | Liver Metastase... | anti-CEA CAR-T ... Sir-Spheres | 18 Years - | Roger Williams Medical Center | |
| HAIC Combined Sintilimab for Liver Metastasis From Esophageal Squamous Cell Carcinoma | NCT06184841 | Hepatic Arteria... Liver Metastase... Esophageal Squa... | HAIC combined w... | 18 Years - 75 Years | Peking University Cancer Hospital & Institute | |
| Real-time Imaging of Holmium Radioembolization: a Feasibility Study | NCT04269499 | Liver Cancer Liver Metastase... | QuiremSpheres® | 18 Years - | Radboud University Medical Center | |
| Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain | NCT00550654 | Kidney Cancer Melanoma (Skin) Metastatic Canc... Ovarian Cancer Sarcoma Unspecified Adu... | questionnaire a... 3-dimensional c... hypofractionate... image-guided ra... tomotherapy | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Isolated Hepatic Perfusion in Combination With Ipilimumab and Nivolumab in Patients With Uveal Melanoma Metastases | NCT04463368 | Uveal Melanoma Liver Metastase... | Isolated hepati... Ipilimumab Nivolumab | 18 Years - | Vastra Gotaland Region | |
| Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors | NCT00093444 | Liver Cancer Metastatic Canc... | lyso-thermosens... radiofrequency ... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Liver Transplantation After ex Vivo Liver Perfusion | NCT05951231 | Liver Transplan... Transplant; Fai... Transplant Dysf... Transplant; Com... Transplant Liver Metastase... Liver Cancer | Liver transplan... | 18 Years - 100 Years | Oslo University Hospital | |
| Phase I Study With AZD2171 in Patients With Advanced Solid Malignant Tumors and Liver Metastases | NCT00501605 | Advanced Solid ... Liver Metastase... | AZD2171 | 18 Years - | AstraZeneca | |
| Phase 2 Study of Thermodox as Adjuvant Therapy With Thermal Ablation (RFA) in Treatment of Metastatic Colorectal Cancer(mCRC) | NCT01464593 | Colon Cancer Li... | Lyso-Thermosens... 5% Dextrose Sol... ThermoDox | 18 Years - | Imunon | |
| HAI-Floxuridine, or Liver-Tx, Combined With 2nd Line Chemotherapy Versus 2nd Line Chemotherapy Alone for Patients With Colorectal Liver Metastases and Heavy Tumour Burden. | NCT04898504 | Colorectal Canc... Liver Metastase... Chemotherapy Ef... | Floxuridine Liver Transplan... | 18 Years - | Oslo University Hospital | |
| The Value of Laparoscopic Ultrasound in Patients Undergoing Laparoscopic Resection for Cancer of the Colon or Rectum | NCT02079389 | Colon Cancer Rectum Cancer Liver Metastase... | Lap+Lus | 18 Years - | Odense University Hospital | |
| Perioperative Platelet Inhibition With Acetylsalicylic Acid in Patients With Resectable Tumors of the Pancreatic Head | NCT05637567 | Pancreatic Canc... | Acetylsalicylic... Placebo | 18 Years - 80 Years | German Cancer Research Center | |
| Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases | NCT00062348 | Colorectal Canc... Head and Neck C... Metastatic Canc... | boronophenylala... sodium borocapt... conventional su... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Treatment of Liver Metastases With Electrochemotherapy (ECTJ) Phase II | NCT02352259 | Liver Metastase... | Electrochemothe... Cliniporator Vi... Bleomycin PHC 1... | 18 Years - | Institute of Oncology Ljubljana | |
| Observational Study for SIR-Spheres Therapy for the Treatment of Unresectable Metastatic Liver Tumors From Primary Colorectal Cancer | NCT06079242 | Colorectal Neop... | Resin microsphe... | 18 Years - | GrandPharma (China) Co., Ltd. | |
| Aspirin in Colorectal Cancer Liver Metastases | NCT03326791 | Colorectal Canc... Colorectal Canc... Liver Metastase... | Acetylsalicylic... Placebo Oral Ta... | 18 Years - | Oslo University Hospital | |
| EPA for Metastasis Trial 2 | NCT03428477 | Liver Metastasi... Colon Cancer | Icosapent Ethyl Placebo | 18 Years - | University of Leeds | |
| Yttrium90, Ipilimumab, & Nivolumab for Uveal Melanoma With Liver Metastases | NCT02913417 | Uveal Melanoma Hepatic Metasta... | SIR-Spheres® Yt... ipilimumab nivolumab | 18 Years - | California Pacific Medical Center Research Institute | |
| Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases | NCT03856658 | Pancreatic Aden... Liver Metastase... | Floxuridine (FU... Hepatic Artery ... Heparinized Sal... | 18 Years - 75 Years | Spectrum Health Hospitals |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
